Results 161 to 165 of about 724,283 (165)

Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.

Inflammatory Bowel Diseases, 2018
Gionata Fiorino, Daniela Gilardi, Silvio Danese   +2 more
exaly  

Molecular Cytogenetics of t(12;21)(p13;q22)

Leukemia and Lymphoma, 1996
Olivier A Bernard, S P Romana, H Poirel
exaly  

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)

Gastroenterology
Jean-Frédéric Colombel, Gahee Park, Maciej Kowalski   +2 more
exaly  

Translocation t(8;16)(p11;p13) in neonatal acute monocytic leukaemia

European Journal of Pediatrics, 1991
I Ono, N Moriyama
exaly  

Characterization of rtSH3p13 gene encoding a development protein involved in vesicular traffic in spermiogenesis

Cell Research, 2004
exaly